Deerfield Management’s Revolution Medicines RVMD Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $125M | Buy |
3,384,072
+66,740
| +2% | +$2.46M | 2.26% | 12 |
|
|
2025
Q1 | $117M | Buy |
3,317,332
+59,000
| +2% | +$2.09M | 2.32% | 11 |
|
|
2024
Q4 | $143M | Buy |
3,258,332
+345,640
| +12% | +$15.1M | 2.7% | 6 |
|
|
2024
Q3 | $132M | Sell |
2,912,692
-177,381
| -6% | -$8.04M | 1.97% | 11 |
|
|
2024
Q2 | $120M | Hold |
3,090,073
| – | – | 2% | 11 |
|
|
2024
Q1 | $99.6M | Hold |
3,090,073
| – | – | 1.73% | 18 |
|
|
2023
Q4 | $88.6M | Buy |
3,090,073
+1,338,577
| +76% | +$38.4M | 1.64% | 18 |
|
|
2023
Q3 | $48.5M | Hold |
1,751,496
| – | – | 1.07% | 25 |
|
|
2023
Q2 | $46.9M | Buy |
1,751,496
+921,759
| +111% | +$24.7M | 1% | 28 |
|
|
2023
Q1 | $18M | Sell |
829,737
-61,850
| -7% | -$1.34M | 0.4% | 56 |
|
|
2022
Q4 | $21.2M | Sell |
891,587
-2,000,000
| -69% | -$47.6M | 0.44% | 59 |
|
|
2022
Q3 | $57M | Buy |
2,891,587
+2,000,000
| +224% | +$39.4M | 1.14% | 28 |
|
|
2022
Q2 | $17.4M | Hold |
891,587
| – | – | 0.36% | 63 |
|
|
2022
Q1 | $22.7M | Hold |
891,587
| – | – | 0.51% | 46 |
|
|
2021
Q4 | $22.4M | Sell |
891,587
-674,125
| -43% | -$17M | 0.47% | 52 |
|
|
2021
Q3 | $43.1M | Hold |
1,565,712
| – | – | 0.84% | 36 |
|
|
2021
Q2 | $49.7M | Buy |
1,565,712
+129,000
| +9% | +$4.09M | 0.88% | 35 |
|
|
2021
Q1 | $65.9M | Buy |
1,436,712
+40,329
| +3% | +$1.85M | 1.39% | 20 |
|
|
2020
Q4 | $55.3M | Sell |
1,396,383
-400,000
| -22% | -$15.8M | 1.09% | 25 |
|
|
2020
Q3 | $62.5M | Hold |
1,796,383
| – | – | 1.52% | 21 |
|
|
2020
Q2 | $56.7M | Hold |
1,796,383
| – | – | 1.65% | 16 |
|
|
2020
Q1 | $39.4M | Buy |
+1,796,383
| New | +$39.4M | 1.25% | 27 |
|